Sunday, November 22, 2026

Scientists from China use CRISPR to remove HIV DNA from human cells

Date:

A research team in China says it has removed HIV genetic material from human cells using CRISPR gene-editing technology. The findings are still at the laboratory stage, but they have drawn global attention because current HIV treatment suppresses the virus – it does not eliminate it.The study, published on December 28 2025, was led by Professor Gu Chaojiang at the College of Life Science and Health, Wuhan University of Science and Technology (WUST). The team developed what it calls an ‘EMT-Cas12a’ system – short for Exosome-Mediated Targeted CRISPR-Cas12a Delivery.

What the China CRISPR HIV study found
CRISPR acts like molecular scissors. It cuts DNA at precise locations.HIV makes treatment difficult because it inserts its genetic code into human DNA. Once integrated, it can remain hidden. Standard antiretroviral therapy (ART) keeps the virus under control, but it cannot remove this embedded genetic material.

The Wuhan team used engineered exosomes – tiny biological carriers – to transport the gene-editing enzyme Cas12a into infected cells. According to their findings, the system was able to target and remove HIV DNA from those cells under laboratory conditions.

If confirmed in further testing, that would mark a shift from suppression to complete removal.

Expert reactions and safety concerns

Biotech entrepreneur Kiran Mazumdar-Shaw described the development as offering “a breakthrough in treating people who have long endured a silent, stigmatised life due to the deadly, life-threatening HIV virus.”

Scientists not involved in the study have urged caution. Most gene-editing advances begin in controlled lab settings. Moving to human trials is a separate step – that process can take years.

There are also safety concerns. Gene editing carries the risk of unintended changes to healthy DNA – so-called off-target effects. Even small errors could create complications.

What this breakthrough means for HIV treatment worldwide

Nearly 40 million people worldwide live with HIV, according to WHO data. Modern ART has transformed the disease into a manageable chronic condition in many countries. Patients, however, must remain on lifelong medication.

A therapy capable of removing the virus from infected cells would change the treatment model. That remains hypothetical for now.

Researchers stress that prevention, regular testing, and existing treatment protocols remain essential – the CRISPR findings represent progress, but not a cure.

Further peer review and clinical validation will determine whether this approach moves beyond the laboratory and into human trials.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

CLSA sees better US-India trade outlook; expects Fed and RBI to raise rates in December

The US is likely to push ahead with trade...

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...